02708nas a2200253 4500000000100000008004100001653002400042653001200066653001700078653002700095653002600122653002300148100001500171700001300186700001700199700001400216700001600230700001400246245011500260856011100375300001200486490000700498520194900505 2018 d10aClinical management10aleprosy10aMetro Manila10aMultibacillary leprosy10aMultiple Drug Therapy10aPatient management1 aPepito VCF1 aAmit AML1 aSamontina RE1 aAbdon SJA1 aFuentes DNL1 aSaniel OP00aVariations in the Clinical Management of Multibacillary Leprosy Patients in Selected Hospitals in Metro Manila uhttp://actamedicaphilippina.org/sites/default/files/fulltexts/52-03/vol52%20no3-8%20Leprosy%20Patients.pdf a268-2760 v523 a

Introduction. This paper documents the variations in the diagnosis and management of multibacillary leprosy patients in three of the biggest case-holding hospitals in Metro Manila. Furthermore, we aimed to discuss the implications of these variations on the country’s leprosy control and elimination program.

Methods. Focus group discussions (FGD) were conducted with 23 health professionals composed of doctors and nurses with at least a year of experience in managing leprosy patients. The topics included procedures on patient diagnosis and management such as treatment duration, patient follow-up and definitions of treatment completion and default. The FGD participants provided suggestions to improve treatment compliance of patients. Their responses were compared with World Health Organization (WHO) standards and/or the 2002 DOH Manual of Operating Procedures (MOP) for leprosy. Transcripts of the recordings of the FGDs were prepared and thematic analysis was then performed.

Results. There were variations in the hospitals’ procedures to diagnose leprosy, in treatment duration, and in patient follow-up. Definitions for treatment completion and default differed not just between hospitals but also with the WHO guidelines and the 2002 MOP. Hospitals extended treatment up to 24 or even 36 months, despite the 12 months stipulated in the MOP. Two hospitals required slit skin smear and skin biopsy in diagnosis, despite the MOP and WHO provisions that these were not mandatory. One hospital defined default as three consecutive months without treatment, which was different from the MOP and WHO standards and from the other hospitals.

Conclusion. Given the variations in patient management, we recommended that effectiveness of the standard treatment relative to other regimens being practiced by specialists be evaluated.